Insider

GE HealthCare appointed Pascal Desroches to its Board of Directors

GE HealthCare announced the appointment of Pascal Desroches, chief financial officer of AT&T, to its Board of Directors, effective January 4, 2027, and chief financial officer William K. Grogan purchased 75,096 shares and 31,877 derivative instruments on September 14, 2026.

Verified against 4 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
long table with Eiffel chair inside room
Photo by Pawel Chu on Unsplash
75,096 shares
Shares bought

Key points

  • The company announced the appointment of Pascal Desroches, senior executive vice president and chief financial officer of AT&T, to the GE HealthCare board, effective January 4, 2027.
  • The new board member’s appointment does not trigger immediate changes to the company’s strategy and does not guarantee higher profitability.

What happened

The company announced the appointment of Pascal Desroches, senior executive vice president and chief financial officer of AT&T, to the GE HealthCare board, effective January 4, 2027. The appointment will be accompanied by compensation under the company’s compensation program for non‑employee directors (the pay plan for outside board members) and the signing of an indemnification agreement (a contract that protects the director from certain liabilities), with no third‑party arrangements.

GE HealthCare chief financial officer William K. Grogan reported in the insider‑transactions filing (Item 4) that he acquired 75,096 common shares and 31,877 derivative instruments on September 14, 2026.

What this does not mean

The new board member’s appointment does not trigger immediate changes to the company’s strategy and does not guarantee higher profitability. The filing does not disclose the transaction terms, so it is unclear whether the purchase was a market transaction or compensation. Information submitted under Item 7.01, including the press release, is not considered “filed” under Section 18 of the Securities Exchange Act, so its regulatory effect is limited.

Original sources

  1. 8-K EX-99 filing, September 22, 2026September 22, 2026SHA-256 of our archived copy 7bc61efee38e…
  2. 8-K filing, September 22, 2026September 22, 2026SHA-256 of our archived copy 1c20a405e164…
  3. 3 filing, September 16, 2026September 16, 2026SHA-256 of our archived copy 2a0472b361b1…
  4. 4 filing, September 16, 2026September 16, 2026SHA-256 of our archived copy 305ca552a016…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards